T
Tyra Biosciences, Inc. (TYRA)
NMS – Real Time Price. Currency in USD
31.88
+0.94 (3.04%)
At close: Jun 26, 2026, 4:00 PM EDT
31.88
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:36 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
31.88
+0.94 (3.04%)
At close: Jun 26, 2026, 4:00 PM EDT
31.88
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:36 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $85.0M significantly exceed its total debt $5.7M, ensuring strong financial flexibility
Total current assets $394.6M exceed Total current liabilities $19.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$32.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 20.49 | 6.05 | 10 | |
| Quick ratio | 20.49 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -296K | -353K | -519K | -546K | -541K |
| Operating Income | -59M | -80M | -104M | -133M | -143M |
| Net Income | -55M | -69M | -86M | -120M | -131M |
| EBITDA | -59M | -80M | -104M | -132M | -142M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -37.96 | 1.0 |
| Next quarter | N/A | -29.99 | 1.0 |
| Current year | N/A | -29.08 | 1.0 |
| Next year | N/A | -9.22 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -16.16 | -12.27 | -37.9 | 3.3 |
| Y/Y | 999 | -39.63 | -36.16 | -28.21 | 3.3 |
| 3y average | 999 | -29.56 | -16.33 | -24.57 | 3.3 |
| 5y average | 999 | -76.14 | -4.53 | -76.85 | 3.3 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |